Bone Biologics Corporation (BBLG) stock rallied over 1.67% intraday to trade at $1.22 a share on NASDAQ. The stock opened with a gain of 1.67% at $1.24 and touched an intraday high of $1.31, rising 1.67% against the last close of $1.2. The stock went to a low of $1.2 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
Bone Biologics Corporation (NASDAQ: BBLG) stock price is $1.22 as of the last check on Wednesday, July 6. During the trading session, BBLG stock reached the peak price of $1.31 while $1.2 was the lowest point it dropped to.
The NASDAQ listed BBLG is part of Biotechnology industry that operates in the broader Health Care sector. Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration.
Mr. Jeffrey Frelick
Pres & CEO
Ms. Deina H. Walsh
Chief Financial Officer
Dr. Shun'ichi Kuroda
Co-Founder & Member of Scientific Advisory Board
BBLG stock traded closed the last session at $1.22, which is $0.02 or 1.67% lower than its previous close of $1.2. BBLG's current trading price is 7.96% lower than its 52-week high of $7.12 where as its distance from 52-week low of 1.13% is -82.87%.
Number of BBLG employees currently stands at -. BBLG operates from 2 Burlington Woods Drive, Suite 100, Burlington, MA 01803, United States.
Official Webiste of $BBLG is: https://www.bonebiologics.com
BBLG stock volume for the day was 9,603 shares while in the previous session number of BBLG shares traded was 9,603 . The average number of BBLG shares traded daily for last 3 months was 25.25 Thousands.
The percentage change in BBLG stock occurred in the recent session was 1.67% while the dollar amount for the price change in BBLG stock was $0.02.
In the recent session, the day high for BBLG stock was $1.31 while the low for BBLG stock touched on the day was $1.2.
The market value of BBLG currently stands at 13.82 Million with its latest stock price at $1.22 and 10.35 Million of its shares outstanding.